Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Glenmark Pharmaceuticals Limited
Press Release Dec 21 2020
Published Dec 21 2020
5 min read

Press Release Dec 21 2020

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 21, 2020, titled "Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg".

View Attachment